Literature DB >> 28272723

Studies on the relationship between P13K/AKT signal pathway-mediated MMP-9 gene and lung cancer.

H Zheng1, J-F Liu.   

Abstract

OBJECTIVE: The present study has been planned to explore the relationship between P13K/AKT signal pathway-mediated matrix metalloproteinase-9 (MMP-9) gene and lung cancer. PATIENTS AND METHODS: The adjacent lesion tissues were removed from 68 cases of patients with lung cancer admitted to our hospital from February 2013 to February 2015. They were selected as observation group, and the pulmonary adjacent normal section specimens from 18 cases were taken as control group. The differences in expression quantities of P13K, AKT and MMP-9 genes in adjacent lesion tissues and adjacent normal tissues were detected by fluorescence quantitative PCR technology, enzyme-linked immunosorbent assay (ELISA), Western-blotting technology and immunohistochemical technique and SP staining technology.
RESULTS: The mRNA expression quantities of P13K, AKT and MMP-9 genes in adjacent lesion tissues increased significantly in comparison to adjacent normal tissues, and the differences were statistically significant (p<0.05). The results of Spearman correlation detection showed that the expression quantity of MMP-9 in adjacent lesion tissues had a significantly positive correlation with that of P13K and AKT (r=0.232, p<0.05).
CONCLUSIONS: MMP-9 gene could promote the generation of lung cancer through P13K/AKT signal pathway, which provides certain theoretical and experimental basis for subsequent diagnosis and treatment of lung cancer.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28272723

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  3 in total

1.  Compound Kushen injection inhibits EMT of gastric cancer cells via the PI3K/AKT pathway.

Authors:  Luo Li; Keshan Wang; Zhenguo Liu; Yajuan Lü; Congcong Wang; Xuefei Yi; Jianping Guo
Journal:  World J Surg Oncol       Date:  2022-05-20       Impact factor: 3.253

2.  Efficacy of radiotherapy on intermediate and advanced lung cancer and its effect on dynamic changes of serum vascular endothelial growth factor and matrix metalloproteinase-9.

Authors:  Guowei Ding; Yongchao Liu; Chunmei Liang
Journal:  Oncol Lett       Date:  2018-05-02       Impact factor: 2.967

3.  Mechanisms of Compound Kushen Injection for the Treatment of Lung Cancer Based on Network Pharmacology.

Authors:  Ziqi Meng; Xinkui Liu; Jiarui Wu; Wei Zhou; Kaihuan Wang; Zhiwei Jing; Shuyu Liu; Mengwei Ni; Xiaomeng Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2019-05-28       Impact factor: 2.629

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.